Acute Respiratory Distress Syndrome (ARDS) Market Forecast and Insights: Exploring Growth Trends, Market Size, and Emerging Opportunities
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
How Are Key Drivers Contributing to the Growth and Expansion of the Acute Respiratory Distress Syndrome (ARDS) Market?
The escalating incidents of pneumonia is projected to accelerate the expansion of the acute respiratory distress syndrome (ARDS) market. Contaminating one or both lungs, pneumonia is an infection that causes the air sacs, or alveoli, of the lungs to be filled with fluid or pus, leading to an inflammatory reaction that worsens the permeability of the blood vessels and leakage of fluid into the alveoli. This in turn, hampers the oxygen and carbon dioxide exchange, thereby causing respiratory distress. For instance, as per the UK-based Centre for Tropical Medicine and Global Health’s findings in November 2023, there was a considerable increase in pneumonia cases in Kenya, soaring to 793,864 in 2022-2023 from 477,186 cases reported in 2020-2021. Consequently, the escalating incidents of pneumonia are fuelling the expansion of the ARDS market.
Acute Respiratory Distress Syndrome (ARDS) Market Driver: Rise in Respiratory Illnesses Expected to Boost the Acute Respiratory Distress Syndrome (ARDS) Market
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13005&type=smp
#What is the Projected CAGR for the Acute Respiratory Distress Syndrome (ARDS) Market Size from 2025 to 2034?
The market for acute respiratory distress syndrome (ARDS) has seen substantial expansion in the past few years. There will be an increase from $1.29 billion in 2024 to $1.42 billion in 2025, amounting to a compound annual growth rate (CAGR) of 10.4%. The upward trend during the historic period is primarily due to advancements in critical care medicine, an aging demographic, developments in pulmonary rehabilitation, and the introduction of multidisciplinary care teams.
The expected market size of acute respiratory distress syndrome (ARDS) is set to witness remarkable expansion in the coming years. Projected to reach $2.17 billion by 2029, it will grow at a compound annual growth rate (CAGR) of 11.1%. Growth in the upcoming period can be linked to many factors such as preparedness in global healthcare, creation of vaccines, management of infectious diseases, telemedicine and remote patient monitoring, and patient-centric care models. The forecast period will also see key trends such as the advent of artificial lung devices, individualized ventilation tactics, protective ventilation for the lungs, and pharmaceutical therapies tailored for different ARDS subtypes.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13005
What New Market Trends Are Reshaping theAcute Respiratory Distress Syndrome (ARDS) Market and Its Opportunities?
Leading businesses in the acute respiratory distress syndrome (ARDS) market are concentrating on creating innovative treatments and supplements like Aviptadil, HSP90 inhibitors, among others in order to maintain their market dominance. Aviptadil is a manufactured vasoactive intestinal peptide (VIP) that attaches specifically to receptors present in lung alveolar type II cells. For instance, giving a solid example, Zuventus Healthcare Ltd., a pharmaceutical production company based in India, initiated the launch of Aviptadil in November 2022 to combat acute respiratory distress syndrome. Aviptadil, a vasoactive intestinal peptide supplement, aids in enhancing respiration and reducing mortality rate in ARDS sufferers. This is achieved via Aviptadil’s proficiency in safeguarding and revitalizing Type-2 Pneumocytes, re-establishing Type-1 Pneumocytes, promoting surfactant synthesis, and subduing IL-6 (interleukin 6) and tumor necrosis factor (TNF)-alpha.
Who Are the Leading Market Players Fueling Growth in the Acute Respiratory Distress Syndrome (ARDS) Market Trend?
Major companies operating in the acute respiratory distress syndrome (ards) market are Johnson & Johnson Services Inc., Novartis AG, GlaxoSmithKline PLC, Medtronic PLC, Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Amgen Inc., Fresenius SE & Co. KGaA, Koninklijke Philips N.V., Baxter International Inc., Teva Pharmaceutical Industries Ltd., CSL Behring, Terumo Corporation, ResMed Inc., Smiths Medical Inc., Dräger Safety AG & Co. KGaA., Getinge AB, Mallinckrodt PLC, Masimo Corporation, United Therapeutics Corporation, Fisher & Paykel Healthcare Corporation Limited, Hamilton Medical AG, Zuventus Healthcare Ltd., Windtree Therapeutics Inc., Faron Pharmaceuticals Oy, AcelRx Pharmaceuticals Inc.
Order Your Report Now For A Swift Delivery:
How is the Global Acute Respiratory Distress Syndrome (ARDS) Market Segemented?
The acute respiratory distress syndrome (ARDS) market covered in this report is segmented –
1) By Type: Diagnosis, Treatment
2) By Cause: COVID-19 Disease 2019 (COVID-19), Sepsis, Inhalation Of Harmful Substances, Severe Pneumonia, Other Causes
3) By Severity: Mild, Moderate, Severe
4) By End User: Hospitals, Clinics, Ambulatory Service Centers, Other End Users
Subsegments:
1) By Diagnosis: Imaging Tests, Blood Tests, Lung Function Tests, Other Diagnostic Methods
2) By Treatment: Mechanical Ventilation, Medications, Extracorporeal Membrane Oxygenation (ECMO), Supportive Care, Other Treatment Options
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=13005&type=smp
Which Geographics are Influencing the Growth of the Acute Respiratory Distress Syndrome (ARDS) Market?
North America was the largest region in the acute respiratory distress syndrome (ARDS) market in 2024. The regions covered in acute respiratory distress syndrome (ARDS) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Reports Similar to the Global Acute Respiratory Distress Syndrome (ARDS) Market 2025, By The Business Research Company:
Respiratory Devices And Equipment (Therapeutic And Diagnostic) Global Market Report 2024
Respiratory Monitoring Devices Global Market Report 2024
Anesthesia And Respiratory Devices Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
